Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News EuroPCR 2025

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

Michael O'Riordan

May 28, 2025

News Conference News CRT 2025

SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years

L.A. McKeown

March 10, 2025

News Conference News PCR London Valves 2024

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Michael O'Riordan

November 26, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

News Conference News SCAI 2024

PCI and TAVI Safe, Even When Done at the Same Time: TVT Registry

L.A. McKeown

May 07, 2024

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

News Daily News

European Societies Define Best Practices for Performing Renal Denervation

Todd Neale

February 21, 2023

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

News Daily News

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Michael O'Riordan

November 06, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for August 2019

Shelley Wood

August 30, 2019

News Daily News

FDA: Class I Recall for Burst Balloons With Sapien 3 Ultra Delivery System

Michael O'Riordan

August 22, 2019

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2019

Shelley Wood

July 31, 2019

News Daily News

Burst Balloons With Sapien 3 Ultra Prompt ‘Urgent Field Safety Notice’ and Canadian Recall

Shelley Wood

July 22, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2019

Caitlin E. Cox

January 31, 2019

Advertisement

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

PCI and TAVI Safe, Even When Done at the Same Time: TVT Registry

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

European Societies Define Best Practices for Performing Renal Denervation

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Sapien 3 Valve Approved in Europe for Low-Risk Patients

TCTMD’s Top 10 Most Popular Stories for August 2019

FDA: Class I Recall for Burst Balloons With Sapien 3 Ultra Delivery System

FDA Expands TAVR Indication to Low-Risk Patients

TCTMD’s Top 10 Most Popular Stories for July 2019

Burst Balloons With Sapien 3 Ultra Prompt ‘Urgent Field Safety Notice’ and Canadian Recall

TCTMD’s Top 10 Most Popular Stories for January 2019

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content